You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Opioid Prescribing: Safe Practice, Changing Lives

  • Authors: Katherine E. Galluzzi, DO; Barbara St. Marie, PhD, ANP, GNP, ACHPN
  • CME / CE Released: 10/20/2015; Reviewed and Renewed: 10/19/2016
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 5/15/2017
Start Activity


Target Audience and Goal Statement

This activity is intended for neurologists, primary care physicians, other physicians, nurses (including advanced practice nurses), physician assistants, pharmacists, dentists, podiatrists, optometrists and other clinicians who may be involved in the treatment of patients who are receiving opioid therapy.

The goal of this activity is to provide education on the safe use of extended-release, long-acting opioid analgesics.

Upon completion of this activity, participants will be able to:

  1. Describe appropriate patient assessment for treatment with ER/LA opioid analgesics
  2. Evaluate the risks and potential benefits of ER/LA opioid analgesics
  3. Summarize the key components of safe use of ER/LA opioid analgesics
  4. Demonstrate accurate knowledge about how to initiate and manage therapy with ER/LA opioid analgesics, including appropriate monitoring for adverse effects and possible misuse


Disclosures

It is the policy of each accrediting body that the planners, faculty, and this provider disclose the existence of any significant financial interest or other relationships that they and/or their spouse/partner may have with the manufacturers of any commercial products or services relating to the topics presented in the educational activity. Each accrediting body also requires disclosure of the intent to discuss unlabeled uses of a commercial product or investigational use of a product not yet approved for this purpose. It is the responsibility of the education committee to review potential conflicts of interest as submitted in the disclosure form and resolve such conflicts. Resolving the conflicts ensures that the content of the activities is aligned with the interests of the public. Attendees will also be informed when no relevant financial relationships exist.


Author(s)

  • Katherine E. Galluzzi, DO

    Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Katherine E. Galluzzi, DO, has disclosed no relevant financial relationships.

    Dr Galluzzi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Galluzzi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Barbara St. Marie, PhD, ANP, GNP, ACHPN

    Associate Faculty, College of Nursing, University of Iowa, Iowa City, Iowa

    Disclosures

    Disclosure: Barbara St. Marie, PhD, ANP, GNP, ACHPN, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Collaborative for REMS Education

    Dr St. Marie does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr St. Marie does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Sarah Williams, PhD

    Senior Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Sarah Williams, PhD, has disclosed no relevant financial relationships.

Independent Content Reviewers

  • Ronald Crossno, MD

    Senior National Hospice Medical Director, Gentiva Health Services, Rockdale, Texas

    Disclosures

    Disclosure: Ronald Crossno, MD, has disclosed no relevant financial relationships.

  • Roberto Cardarelli, DO, MPH, FAAFP

    University of Kentucky College of Medicine, Lexington, Kentucky

    Disclosures

    Disclosure: Roberto Cardarelli, DO, MPH, FAAFP, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Pfizer Inc.

Content Reviewer

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Acknowledgement
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see here for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

About CO*RE


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    This Enduring Material activity, Opioid Prescribing: Safe Practice, Changing Lives has been reviewed and is acceptable for up to 2.00 Prescribed credit(s) by the American Academy of Family Physicians. Term of approval begins 03/24/2015. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    For Physician Assistants

    This program has been reviewed and is approved for a maximum of 2 hours of AAPA Category I CME credit by the Physician Assistant Review Panel. Approval is valid for one year from the issue date. Participants may submit the self-assessment at any time during that period.

    This program was planned in accordance with AAPA’s CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

    Successful completion of the self-assessment is required to earn Category I CME credit. Successful completion is defined as a cumulative score of at least 70% correct.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 2.0 contact hour(s) of continuing nursing education for RNs and APNs; 2.0 contact hours are in the area of pharmacology.

    For Nurse Practitioners


    This program is approved for 2.0 contact hours of continuing education (which includes 2.0 hours of pharmacology) by the American Association of Nurse Practitioners. Program ID 1307268

    This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Medscape designates this continuing education activity for 2.0 contact hour(s) (0.20 CEUs) (Universal Activity Number 0461-0000-15-122-H05-P)

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Opioid Prescribing: Safe Practice, Changing Lives

Authors: Katherine E. Galluzzi, DO; Barbara St. Marie, PhD, ANP, GNP, ACHPNFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / CE Released: 10/20/2015; Reviewed and Renewed: 10/19/2016

Valid for credit through: 5/15/2017

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Section 1. Assessing Patients and Initiating Opioid Therapy
How do you decide whether an ER/LA opioid is appropriate?
Katherine E. Galluzzi, DO; Barbara St Marie, PhD, ANP-BC, GNP-BC, ACHPN
Section 2. Managing and Monitoring Therapy
Recognizing the red flags to possible misuse.
Katherine E. Galluzzi, DO
Section 3. A Summary of Take-Home Messages
A quick review of the practice pearls.
Katherine E. Galluzzi, DO
  • Print